EUVIMEDEUVIMED entdecken
Leserbrief

Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Reduces Infarct Size Independently of Sodium Glucose Cotransporter-2

Sha Chen, Qian Wang, Andriana Christodoulou, Nikolaos Mylonas, Diane Bakker, Rianne Nederlof, Markus W Hollmann iD, Nina C Weber iD, Ruben Coronel, Vincent Wakker iD, Vincent M Christoffels iD, Ioanna Andreadou und 1 weitere

Circulation · 17.01.2023 · 147 (3) · 276-279

DOI: 10.1161/circulationaha.122.061688 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Circulation, erschienen am 17.01.2023. Verfasst von Sha Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Experimental Intensive Care and Anesthesiology, Department of Anesthesiology (S.C., Q.W., D.B., M.W.H.., N.C.W., C.J.Z.), Amsterdam Car…. Hauptthemen laut MEDLINE: Sodium-Glucose Transporter 2 Inhibitors, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 99-mal zitiert (Crossref) und nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sodium-Glucose Transporter 2 InhibitorsDiabetes Mellitus, Type 2HumansHypoglycemic AgentsBenzhydryl CompoundsGlucoseGlucosides

Stichwörter der Autor:innen

body weightempagliflozinglucoseinfarct sizeischemia/reperfusionketonessodium-glucose cotransporter 2 inhibitor

Substanzen

Sodium-Glucose Transporter 2 InhibitorsHypoglycemic AgentsBenzhydryl CompoundsGlucoseempagliflozinGlucosides

Autor:innen und Institutionen

  • Laboratory of Experimental Intensive Care and Anesthesiology, Department of Anesthesiology (S.C., Q.W., D.B., M.W.H.., N.C.W., C.J.Z.), Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, the Neth…
  • Laboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian University of Athens, Greece (A.C., N.M., I.A.).
  • Institut für Herz- und Kreislaufphysiologie, Medizinische Fakultät und Universitätsklinikum Düsseldorf, Heinrich-Heine-Universität Düsseldorf, Germany (R.N.).
  • Department of Experimental Cardiology (R.C.), Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, the Netherlands.
  • Department of Medical Biology (V.W., V.M.C.), Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, the Netherlands.

ORCID-Profile: Markus W Hollmann, Nina C Weber, Vincent Wakker, Vincent M Christoffels, Coert J Zuurbier

Zitieren

APA

Chen, S., Wang, Q., Christodoulou, A., Mylonas, N., Bakker, D., Nederlof, R., Hollmann, M. W., Weber, N. C., Coronel, R., Wakker, V., Christoffels, V. M., Andreadou, I., & Zuurbier, C. J. (2023). Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Reduces Infarct Size Independently of Sodium Glucose Cotransporter-2. Circulation, 147(3), 276-279. https://doi.org/10.1161/circulationaha.122.061688

Vancouver

Chen S, Wang Q, Christodoulou A, Mylonas N, Bakker D, Nederlof R, et al. Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Reduces Infarct Size Independently of Sodium Glucose Cotransporter-2. Circulation. 2023;147(3):276-279. doi:10.1161/circulationaha.122.061688

BibTeX
@article{Chen2023,
  author = {Chen, Sha and Wang, Qian and Christodoulou, Andriana and Mylonas, Nikolaos and Bakker, Diane and Nederlof, Rianne and Hollmann, Markus W and Weber, Nina C and Coronel, Ruben and Wakker, Vincent and Christoffels, Vincent M and Andreadou, Ioanna and Zuurbier, Coert J},
  title = {Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Reduces Infarct Size Independently of Sodium Glucose Cotransporter-2},
  journal = {Circulation},
  year = {2023},
  volume = {147},
  number = {3},
  pages = {276--279},
  doi = {10.1161/circulationaha.122.061688}
}
Kostenlos starten →